Bayer, "our collaborations with our partners at http://Avicenna.AI, Riverain Technologies, icometrix, and Imaging Biometrics, LLC were instrumental in providing all the necessary support to substantiate our value claims and quantify them meaninfully"
https://www.sciencedirect.com/science/article/pii/S1546144024002928
“Funding for Glioblastoma research is now available through the DOD’s Peer Reviewed Medical Research Program (PRMRP). Don't wait to apply, the deadlines are coming up fast in early May”
They way the last part reads is it’s for patients. Then if you click the link it explains what it’s for
https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=23621290&fileType=pdf
This is how out of touch the people in control of this company are with reality.
They decided to post the mussella YouTube video on twitter as if nobody has seen it!!
Here's the
@AlMusella
webinar "oral gallium maltolate (GaM) for brain tumors" featuring Dr. Connelly and 2 patients. GaM is the agent under study in
@IQAI_IB
's sponsored phase 1 trial.
Only 11 days old!
Hopeium is not a good investment.
The thing everyone is forgetting is Trevor our CEO has been doing this for a long time probably before I was even born. In my opinion he knows exactly what he’s doing and knows how bad the current personal investors sentiment is and that’s what is frustrating me the most he doesn’t care and doesn’t seem to think anything needs to be done about it as it’s not affecting him. He gets to call all the shots and he gets to feed us pesants the information he thinks we should have and no more.
The only thing I would say is by selling out at the lows you’re letting him win as in my opinion that’s why it’s low as he controls the news flow which technically controls the share price. It’s a waiting game and he will know that as he’s shown his cards there will be a big sell off into any positive news flow.
Or he’s just thick as pigs sht and arrogant and thinks everything is rosy and he and his bod are doing a wonderful job which would explain the grant of options. I’m pretty sure all shareholders have to vote to reinstate him at this years agm so we could all out vote them.
With the share price this low it is a sitting duck for a major that could take advantage of the low price and buy us out with pocket change.
GLA!!
Sad really that you speak the truth and many people agreed then someone who doesn’t want it posted up for all to see gets the post removed. I wonder who that could have been.
Rather than worry about your shareholders speaking the truth why not do your job and add value for all shareholders rather than take.
Still no removed YouTube video reposted. Still no reassurance for the loyal long term shareholders screwed over by the scummy CEO. Kind of speaks for itself.
Trek don’t forget this is like playing poker with someone who can see every card even yours. It wouldn’t surprise me if they’ve already started discussing with a 3rd party about funding/progressing phase 2, but he doesn’t yet want us and other shareholders to know only the select few.
Also it’s extremely frustrating that they still haven’t released the video that was removed!
You may have to go via this link as I don’t think they allow telegram links
https://twitter.com/kaneinthename/status/1765791587282350433
As pointed out earlier fab have taken a 3.68% holding in CMH not sure why it took them roughly 6 weeks to notify the market. Thinking we might see the same here possibly waiting for the dust to settle. I thought you had 3 days?? Guess certain individuals don’t have to play by the rules!
5. Date on which the threshold was crossed or reached vi:
15 January 2024
6. Date on which issuer notified (DD/MM/YYYY): 27th February 2024
Presentations have been presented to a select few. Made public then removed with no reasonable explanation.
The company has no pr and relies on shareholders sharing information on bulletin boards. Sometimes posters have shared information about the company before they have, showing a lack of interest or enthusiasm to maximise ALL shareholder value.
The company has recently chosen to issue price sensitive information via social media platforms rather than issue rns. Meaning not all shareholders could have access to the information and again the company relying on the information to be passed on via bulletin boards or telegram groups.
The CEO issued half/final reports stating the companies share price is undervalued and described how:
“We believe that the cumulative accretion of value during this time is not adequately reflected in the current market valuation of the Company, and we are now considering how best to address this anomaly.”
“The key drivers are all shareholders, who have had to become accustomed to the vagaries of the stock market and how it values the Company`s shares. Oftentimes the market capitalization of the Company has changed over a small number of trading days by 10-25% without any discernable reason”
Also the CEO stated:
“More than 45 different hospitals and healthcare systems are at varying stages of evaluating our software, with more sites entering the sales pipeline. This step-change in pre-sales activity is approximately a seven-fold increase over previous periods”
“Our objective for the remainder of the year is to convert as many of the 45 sites currently evaluating IB Software”
Either they made no sales from 45 leads or have chosen not to disclose any new sales. As nothing has been reported to shareholders since these reports.
From a recent rns shareholder letter we were told.
“We have identified a large new grant opportunity that is specific to our core imaging technologies, and we are evaluating potential aims for a February submission.”
Again another comment that has been issued via an rns but nothing more has been spoken of. Meaning shareholders are just supposed to forget they said it.
Either the company and its board of directors are seriously out of its depth in managing shareholder expectations or they are not interested in maximising ALL shareholder value and are only interested in looking after themselves.
So after roughly 6 months of being told one thing and the company doing the opposite they announced to the market a placing raising £300k at 1.5p. How is this maximising all shareholder value this raise is a direct contradiction of the comments made in official documents. This price is roughly an 80% discount to the market price at the beginning of January. It will be interesting to see who has taken the placing when these shares are issued on 1st March. If we get to see. Potentially proving further that the recent price crash has been orchestrated
“Call a EGM with a single resolution, to remove the CEO, you need a group holding 5% to do this, might be easier to simply sell. The publicity will spur even if you have to withdraw the resoltution, there is lots on this area if you research similar cases”
This was Trevor’s advice to feedback plc shareholders on the advfn board that he regularly posts abuse at them on.
I’m sure between us we have well over over 5%. We could even remove the bent brokers and appoint new ones.
I’ve been in here a long time and am happy to admit when I break even I’m out as all trust is lost and I will avoid anything he or even peterhouse are involved with in the future. The disrespect shown here in the last couple months added with the comments in the final/half year results show that what they say and do are 2 different things and unfortunately now whatever they release by rns I won’t fully trust. Not that they even care about releasing rns’s as most of the news recently has been released on twitter.
Also does anyone else think that video the other week was released not for us but for those taking the placing. It will probably be released again. With regards to people thinking who has taken the placing imo we won’t see any tr1s as normally the include this information in the placing rns, whether it’s tb or anyone else and like most rns this was vague.
GLA!!! I think we may need it
The key drivers are all shareholders, who have had to become accustomed to the vagaries of the stock market and how it values the Company`s shares. Oftentimes the market capitalization of the Company has changed over a small number of trading days by 10-25% without any discernable reason, however we remain firmly focused on the medium-term commercial prospects for our unique products and are confident that shareholder patience will be eventually rewarded.
It is five years since IQ-AI acquired Imaging Biometrics. Throughout that time the IB team have worked continuously and intensively to innovate and develop what has now become a valuable portfolio of medical IP. We believe that the cumulative accretion of value during this time is not adequately reflected in the current market valuation of the Company, and we are now considering how best to address this anomaly.
More than 45 different hospitals and healthcare systems are at varying stages of evaluating our software, with more sites entering the sales pipeline. This step-change in pre-sales activity is approximately a seven-fold increase over previous periods and is due, in large part, to the traction gained from our platform partners including TeraRecon (Eureka) and Bayer (Calantic). These partners have the medical expertise and marketing reach to sell our technologies into large existing installed customer bases and have ample sales and marketing resources to win clients.
It is a relatively easy up-sell for IB's partners' sales teams to activate IB's technology on platforms already being used clinically. The number of sites evaluating our software continues to increase. Thus, we are optimistic about the revenue activity and anticipate a step-change starting in the 2nd half of 2023.
Our objective for the remainder of the year is to convert as many of the 45 sites currently evaluating IB Software, to client status though sales and to harness the momentum from the Phase 1 clinical trial to accelerate the planning for a Phase 2 trial.
These are all quotes taken from the half year and final reports. Whatever happened to the 45 sites evaluating IB software? Either they’ve converted some into sales and not told us (ALL SHAREHOLDERS) or 45 sites said no. Since these comments the share price has fallen off a cliff and there’s obviously a reason but this reason is not being relayed to ALL SHAREHOLDERS. Why? I just don’t understand the games being played. We listed on the us market and had no interest because we didn’t do any pr at all. Now we’ve got the same problem. If you want to run this company as a private company then do it but you will have to buy us out first until then have some self respect and update your shareholders. I don’t understand publicly saying one thing and then doing the complete opposite. You are just making yourself look like a tit!!
Published - a practical guide for DSC-MRI perfusion imaging from the #SchmaindaLab at
@MedicalCollege
. Grateful to have such a DSC powerhouse in IB's corner!
https://www.frontiersin.org/articles/10.3389/fradi.2024.1307586